[go: up one dir, main page]

DE60334533D1 - Gewebe-engineering - Google Patents

Gewebe-engineering

Info

Publication number
DE60334533D1
DE60334533D1 DE60334533T DE60334533T DE60334533D1 DE 60334533 D1 DE60334533 D1 DE 60334533D1 DE 60334533 T DE60334533 T DE 60334533T DE 60334533 T DE60334533 T DE 60334533T DE 60334533 D1 DE60334533 D1 DE 60334533D1
Authority
DE
Germany
Prior art keywords
tissue engineering
engineering
lifespan
extending
general
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60334533T
Other languages
English (en)
Inventor
Laura E Niklason
Andrew J Mckee
Christopher M Counter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duke University
Original Assignee
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duke University filed Critical Duke University
Application granted granted Critical
Publication of DE60334533D1 publication Critical patent/DE60334533D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1276RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/069Vascular Endothelial cells
    • C12N5/0691Vascular smooth muscle cells; 3D culture thereof, e.g. models of blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/04Immortalised cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/30Synthetic polymers
    • C12N2533/40Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60334533T 2002-03-15 2003-03-17 Gewebe-engineering Expired - Lifetime DE60334533D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36408702P 2002-03-15 2002-03-15
PCT/US2003/008054 WO2003078597A2 (en) 2002-03-15 2003-03-17 Tissue engineering

Publications (1)

Publication Number Publication Date
DE60334533D1 true DE60334533D1 (de) 2010-11-25

Family

ID=28041870

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60334533T Expired - Lifetime DE60334533D1 (de) 2002-03-15 2003-03-17 Gewebe-engineering

Country Status (8)

Country Link
US (1) US7943378B2 (de)
EP (1) EP1487274B1 (de)
AT (1) ATE484195T1 (de)
AU (1) AU2003233404A1 (de)
CA (1) CA2479512C (de)
DE (1) DE60334533D1 (de)
ES (1) ES2353665T3 (de)
WO (1) WO2003078597A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE332964T1 (de) * 2000-08-16 2006-08-15 Univ Duke Mittels gewebetechnologie hergestellte dezellularisierte gegenstände und gewebe
US20060052324A1 (en) * 2004-08-05 2006-03-09 Artandi Steven E Methods and compositions for cell activation
EP1693025A1 (de) 2005-02-17 2006-08-23 Universität Zürich Verfahren zur Herstellung einer Prothese aus Gewebe
US20130013083A1 (en) * 2011-01-06 2013-01-10 Humacyte Tissue-Engineered Constructs
EP4190285A1 (de) * 2011-01-06 2023-06-07 Humacyte, Inc. Gewebegezüchtete konstrukte

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6172210B1 (en) 1996-04-02 2001-01-09 Blood Center Research Foundation DNA encoding phospholipid scramblase
US6331406B1 (en) * 1997-03-31 2001-12-18 The John Hopkins University School Of Medicine Human enbryonic germ cell and methods of use
EP0893493A3 (de) 1997-07-21 2002-12-04 Aventis Pharma Deutschland GmbH Genetisch veränderte Zellen und deren Verwendung in der Prophylaxe oder Therapie von Erkrankungen
AU2219999A (en) * 1998-01-12 1999-07-26 Betagene, Inc. Methods for preparing and using immortalized human neuroendocrine cells
US6399384B1 (en) * 1999-09-17 2002-06-04 Reneuron Limited Conditional immortalization of cells
ATE356640T1 (de) * 2000-11-20 2007-04-15 California Inst Of Techn Für den glatten muskel von arterien und den glatten muskel von venen spezifische proteine und deren verwendung
US20040044403A1 (en) * 2001-10-30 2004-03-04 Joyce Bischoff Tissue-engineered vascular structures
US7504258B2 (en) * 2001-12-11 2009-03-17 Cytograft Tissue Engineering, Inc. Tissue engineered cellular sheets, methods of making and use thereof
US20030175961A1 (en) * 2002-02-26 2003-09-18 Herron G. Scott Immortal micorvascular endothelial cells and uses thereof

Also Published As

Publication number Publication date
EP1487274B1 (de) 2010-10-13
WO2003078597A9 (en) 2003-12-11
AU2003233404A8 (en) 2003-09-29
CA2479512C (en) 2012-10-16
EP1487274A2 (de) 2004-12-22
ES2353665T3 (es) 2011-03-03
CA2479512A1 (en) 2003-09-25
US7943378B2 (en) 2011-05-17
AU2003233404A1 (en) 2003-09-29
WO2003078597A2 (en) 2003-09-25
EP1487274A4 (de) 2006-06-21
ATE484195T1 (de) 2010-10-15
US20030235562A1 (en) 2003-12-25
WO2003078597A3 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
BRPI0312331A2 (pt) composições de ácido hialurônico e métodos de emprego.
ATE489101T1 (de) Wiederherstellung der gelenken mit mesenchymalen stammzellen
BRPI0409367A (pt) derivados de piperidina inibidores de renina
UY27143A1 (es) Inhibidores de sulfonamida lactama de fxa y método
EA200900344A1 (ru) Циклические ингибиторы 11-бета-гидроксистероиддегидрогеназы типа i
NO20062649L (no) Biarylsulfonamider og metoder for anvendelse av disse
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
PL375900A1 (en) Dosage forms containing a proton pump inhibitor, a nsaid, and a buffer
TW200519089A (en) Biaryl sulfonamides and methods for using same
BRPI0410467A (pt) composições e métodos para tratamento de sìndrome respiratória aguda severa (sars)
UA84406C2 (ru) Способ обеспечения резистентности к грибковому или грибоподобному патогену в однодольных растениях
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
ECSP045466A (es) Inhibidores de la peptido-desformilasa
TW200508233A (en) Chk-1 inhibitors
WO2007028079A3 (en) Methods of stimulating expansion of hematopoietic stem cells
DE602004029376D1 (de) Fettzusammensetzung für backware, sowie backware
HRP20050439B1 (hr) Nova upotreba dekstran sulfata
FR2872431B1 (fr) Utilisation de fibroplastes gingivaux en therapie cellulaire vasculaire
ATE484195T1 (de) Gewebe-engineering
MX2007002277A (es) Metodos para formar retinoides y usos de los mismos.
DE50305974D1 (de) Rollstuhl, insbesondere Elektrorollstuhl
MX2007002917A (es) Todo-trans-retinol: todo-trans-13, 14-dihidrorretinol saturasa y metodos de uso de la misma.
ITRM20020115A0 (it) Espressione di enzimi lisosomiali in seme.
ATE395092T1 (de) Zementierbare endoprothesen
HRP20090513T1 (hr) S-mirtazapin, namijenjen liječenju napadaja vrućine